GlaxoSmithKline Unveils Cost-Saving Plan

Related Link: 

GlaxoSmithKline announced new cost savings, plans to explore a partial listing of its ViiV Healthcare business and better-than-expected earnings.

Total Names Patrick Pouyanné CEO

Related Link: 

Total named refining and chemicals head Patrick Pouyanné as its new chief executive, after the death of Christophe de Margerie in a Moscow plane crash.

Yelp Posts Second Profitable Quarter

Related Link: 

Yelp Inc. swung to a profit in the third-quarter, just the second period the San Francisco business-review website has reported on the black side of the ledger since its market debut in March 2012.

Mexican Soda Tax Effect Waning, Coca-Cola Femsa Says

Related Link: 

Sparkling beverage sales declined modestly during the third quarter for Coca-Cola Femsa, signaling Mexico’s new tax on sugary drinks might be having less of an impact on consumer spending than at the start of the year.

Google Japan Case Raises Privacy Issues

Related Link: 

A Japanese man who won a court order requiring Google to remove certain search results has asked the court to fine the company, saying it failed to fully remove results that could injure his reputation.

Rosneft Seeks More Aid from Russian Government

Related Link: 

Russia’s largest oil company, state-controlled Rosneft, has asked the government for over 2 trillion rubles ($49 billion) in aid to weather Western sanctions.

Interpublic Earnings Nearly Double

Related Link: 

Interpublic Group said its third-quarter earnings nearly doubled as revenue grew in both the domestic and international markets

Ex-Im Bank's Uncertain Future Worries Small Firms

Related Link: 

A decision by Congress to extend the Export-Import Bank only temporarily is raising concern among business owners who say they rely on the credit agency to lower the risks of exporting.

AT&T Lowers Revenue Outlook

Related Link: 

AT&T lowered its revenue outlook for the year, pointing to fewer-than-expected sign-ups for its no-contract Next wireless plans that require customers to pay full price for their smartphones.

Abbott Sales Rise, Mylan Deal Tweaked

Related Link: 

Abbott tweaked the terms of its agreement to sell a portion of its generic-drugs business to Mylan for $5.3 billion, signaling the deal will be completed despite new Treasury department rules.

Syndicate content